These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25317655)

  • 1. Revisiting the Roco G-protein cycle.
    Terheyden S; Ho FY; Gilsbach BK; Wittinghofer A; Kortholt A
    Biochem J; 2015 Jan; 465(1):139-47. PubMed ID: 25317655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations.
    Rudi K; Ho FY; Gilsbach BK; Pots H; Wittinghofer A; Kortholt A; Klare JP
    Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26310572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roc-COR tandem domain of leucine-rich repeat kinase 2 forms dimers and exhibits conventional Ras-like GTPase properties.
    Mills RD; Liang LY; Lio DS; Mok YF; Mulhern TD; Cao G; Griffin M; Kenche VB; Culvenor JG; Cheng HC
    J Neurochem; 2018 Nov; 147(3):409-428. PubMed ID: 30091236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unconventional G-protein cycle of LRRK2 and Roco proteins.
    Terheyden S; Nederveen-Schippers LM; Kortholt A
    Biochem Soc Trans; 2016 Dec; 44(6):1611-1616. PubMed ID: 27913669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and kinetic properties of the complex Roco G-protein cycle.
    Wauters L; Terheyden S; Gilsbach BK; Leemans M; Athanasopoulos PS; Guaitoli G; Wittinghofer A; Gloeckner CJ; Versées W; Kortholt A
    Biol Chem; 2018 Nov; 399(12):1447-1456. PubMed ID: 30067506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roco Proteins: GTPases with a Baroque Structure and Mechanism.
    Wauters L; Versées W; Kortholt A
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.
    Nguyen AP; Moore DJ
    Adv Neurobiol; 2017; 14():71-88. PubMed ID: 28353279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment.
    Klein CL; Rovelli G; Springer W; Schall C; Gasser T; Kahle PJ
    J Neurochem; 2009 Nov; 111(3):703-15. PubMed ID: 19712061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkinson disease gene LRRK2: evolutionary and structural insights.
    Marín I
    Mol Biol Evol; 2006 Dec; 23(12):2423-33. PubMed ID: 16966681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.
    Guo L; Gandhi PN; Wang W; Petersen RB; Wilson-Delfosse AL; Chen SG
    Exp Cell Res; 2007 Oct; 313(16):3658-70. PubMed ID: 17706965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and nucleotide-induced conformational dynamics of the
    Deyaert E; Leemans M; Singh RK; Gallardo R; Steyaert J; Kortholt A; Lauer J; Versées W
    Biochem J; 2019 Jan; 476(1):51-66. PubMed ID: 30538153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain.
    Li X; Qi Z; Ni D; Lu S; Chen L; Chen X
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase.
    Gotthardt K; Weyand M; Kortholt A; Van Haastert PJ; Wittinghofer A
    EMBO J; 2008 Aug; 27(16):2239-49. PubMed ID: 18650931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific Nanobodies.
    Leemans M; Galicia C; Deyaert E; Daems E; Krause L; Paesmans J; Pardon E; Steyaert J; Kortholt A; Sobott F; Klostermeier D; Versées W
    Biochem J; 2020 Apr; 477(7):1203-1218. PubMed ID: 32167135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.
    Daniëls V; Vancraenenbroeck R; Law BM; Greggio E; Lobbestael E; Gao F; De Maeyer M; Cookson MR; Harvey K; Baekelandt V; Taymans JM
    J Neurochem; 2011 Jan; 116(2):304-15. PubMed ID: 21073465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCO kinase activity is controlled by internal GTPase function.
    Weiss B
    Sci Signal; 2008 Jun; 1(23):pe27. PubMed ID: 18544747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
    Taymans JM; Vancraenenbroeck R; Ollikainen P; Beilina A; Lobbestael E; De Maeyer M; Baekelandt V; Cookson MR
    PLoS One; 2011; 6(8):e23207. PubMed ID: 21858031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GTPase function of LRRK2.
    Taymans JM
    Biochem Soc Trans; 2012 Oct; 40(5):1063-9. PubMed ID: 22988866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of GTPase activity to LRRK2-associated Parkinson disease.
    Tsika E; Moore DJ
    Small GTPases; 2013; 4(3):164-70. PubMed ID: 24025585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2.
    Biosa A; Trancikova A; Civiero L; Glauser L; Bubacco L; Greggio E; Moore DJ
    Hum Mol Genet; 2013 Mar; 22(6):1140-56. PubMed ID: 23241358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.